• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 受体与阿尔茨海默病:一项遗传与功能研究。

Vitamin D receptor and Alzheimer's disease: a genetic and functional study.

机构信息

Hussman Institute for Human Genomics, University of Miami Miller School of Medicine 1501 NW 10 Ave, Miami, Florida, USA.

出版信息

Neurobiol Aging. 2012 Aug;33(8):1844.e1-9. doi: 10.1016/j.neurobiolaging.2011.12.038. Epub 2012 Feb 4.

DOI:10.1016/j.neurobiolaging.2011.12.038
PMID:22306846
Abstract

Genetic studies on late-onset Alzheimer's disease (AD) have repeatedly mapped susceptibility loci onto chromosome 12q13, encompassing the vitamin D receptor (VDR) gene. Epidemiology studies have indicated vitamin D insufficiency as a risk factor for AD. Given that VDR is the major mediator for vitamin D's actions, we sought to clarify the role of VDR in late-onset AD. We conducted an association study in 492 late-onset AD cases and 496 controls with 80 tagging single nucleotide polymorphisms (SNPs). The strongest association was found at a promoter SNP rs11568820 (P = 9.1 × 10(-6), odds ratio (OR) = 1.69), which resides within the transcription factor Cdx-2 binding site and the SNP has been also known as CDX2. The risk-allele at rs11568820 is associated with lower VDR promoter activity (p < 10(-11)). The overexpression of VDR or vitamin D treatment suppressed amyloid precursor protein (APP) transcription in neuroblastoma cells (p < 0.001). We provide both statistical evidence and functional data suggesting VDR confers genetic risk for AD. Our findings are consistent with epidemiology studies suggesting that vitamin D insufficiency increases the risk of developing AD.

摘要

针对迟发性阿尔茨海默病(AD)的遗传研究已多次将易感基因定位于包含维生素 D 受体(VDR)基因的 12q13 染色体上。流行病学研究表明,维生素 D 不足是 AD 的一个危险因素。鉴于 VDR 是维生素 D 作用的主要介质,我们试图阐明 VDR 在迟发性 AD 中的作用。我们对 492 例迟发性 AD 病例和 496 例对照进行了关联研究,共使用了 80 个标记单核苷酸多态性(SNP)。在启动子 SNP rs11568820 处发现了最强的关联(P = 9.1×10(-6),比值比(OR)= 1.69),该 SNP 位于转录因子 Cdx-2 结合位点内,并且该 SNP 也被称为 CDX2。rs11568820 的风险等位基因与 VDR 启动子活性降低相关(p < 10(-11))。VDR 或维生素 D 治疗过表达可抑制神经母细胞瘤细胞中的淀粉样前体蛋白(APP)转录(p < 0.001)。我们提供了统计证据和功能数据,表明 VDR 赋予 AD 的遗传风险。我们的发现与表明维生素 D 不足会增加 AD 发病风险的流行病学研究一致。

相似文献

1
Vitamin D receptor and Alzheimer's disease: a genetic and functional study.维生素 D 受体与阿尔茨海默病:一项遗传与功能研究。
Neurobiol Aging. 2012 Aug;33(8):1844.e1-9. doi: 10.1016/j.neurobiolaging.2011.12.038. Epub 2012 Feb 4.
2
Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.维生素D受体(VDR)基因多态性与单倍型、与血浆25-羟基维生素D和1,25-二羟基维生素D的相互作用以及前列腺癌风险
Prostate. 2007 Jun 15;67(9):911-23. doi: 10.1002/pros.20570.
3
The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene.人类维生素D受体基因中尾相关同源结构域蛋白Cdx-2结合元件的多态性。
J Bone Miner Res. 2001 Jul;16(7):1256-64. doi: 10.1359/jbmr.2001.16.7.1256.
4
Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.巴基斯坦南部患者中维生素D受体Cdx-2基因多态性与绝经前乳腺癌风险
PLoS One. 2015 Mar 23;10(3):e0122657. doi: 10.1371/journal.pone.0122657. eCollection 2015.
5
Vitamin D status and the Cdx-2 polymorphism of the vitamin D receptor gene are determining factors of bone mineral density in young healthy postmenopausal women.维生素 D 状态和维生素 D 受体基因的 Cdx-2 多态性是年轻健康绝经后妇女骨密度的决定因素。
J Steroid Biochem Mol Biol. 2013 Jul;136:187-9. doi: 10.1016/j.jsbmb.2012.09.026. Epub 2012 Sep 28.
6
Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.Cdx2基因多态性影响人乳腺癌细胞系及人乳腺癌组织中维生素D受体的活性。
PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015.
7
Association of vitamin D receptor gene variants, adiposity and colon cancer.维生素D受体基因变异、肥胖与结肠癌的关联
Carcinogenesis. 2008 Sep;29(9):1788-93. doi: 10.1093/carcin/bgn166. Epub 2008 Jul 14.
8
The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine.尾型相关同源结构域蛋白Cdx-2调节小肠中的维生素D受体基因表达。
J Bone Miner Res. 1999 Feb;14(2):240-7. doi: 10.1359/jbmr.1999.14.2.240.
9
Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.人类维生素D受体基因启动子区域的Cdx-2多态性决定了老年人骨折的易感性。
J Bone Miner Res. 2003 Sep;18(9):1632-41. doi: 10.1359/jbmr.2003.18.9.1632.
10
Association between vitamin D receptor gene polymorphism and Alzheimer's disease.维生素D受体基因多态性与阿尔茨海默病之间的关联。
Tohoku J Exp Med. 2007 Jul;212(3):275-82. doi: 10.1620/tjem.212.275.

引用本文的文献

1
A Narrative Review on the Neuroprotective Effects of Selenium and Vitamin D in Alzheimer's Disease.关于硒和维生素D对阿尔茨海默病神经保护作用的叙述性综述
Biol Trace Elem Res. 2025 Aug 14. doi: 10.1007/s12011-025-04788-7.
2
Candidate SNP Markers Significantly Altering the Affinity of the TATA-Binding Protein for the Promoters of Human Genes Associated with Primary Open-Angle Glaucoma.候选单核苷酸多态性标记显著改变TATA结合蛋白与原发性开角型青光眼相关人类基因启动子的亲和力。
Int J Mol Sci. 2024 Nov 28;25(23):12802. doi: 10.3390/ijms252312802.
3
Role of Calcitriol and Vitamin D Receptor () Gene Polymorphisms in Alzheimer's Disease.
骨化三醇和维生素 D 受体()基因多态性在阿尔茨海默病中的作用。
Int J Mol Sci. 2024 Apr 28;25(9):4806. doi: 10.3390/ijms25094806.
4
Associations of vitamin D receptor polymorphisms with risk of Alzheimer's disease, Parkinson's disease, and mild cognitive impairment: a systematic review and meta-analysis.维生素D受体基因多态性与阿尔茨海默病、帕金森病及轻度认知障碍风险的关联:一项系统综述和荟萃分析
Front Aging Neurosci. 2024 Apr 12;16:1377058. doi: 10.3389/fnagi.2024.1377058. eCollection 2024.
5
Vitamin D and neurodegenerative diseases.维生素D与神经退行性疾病
Heliyon. 2023 Jan 12;9(1):e12877. doi: 10.1016/j.heliyon.2023.e12877. eCollection 2023 Jan.
6
Interdisciplinary Approaches to Deal with Alzheimer's Disease-From Bench to Bedside: What Feasible Options Do Already Exist Today?应对阿尔茨海默病的跨学科方法——从实验室到临床:当今已有哪些可行方案?
Biomedicines. 2022 Nov 14;10(11):2922. doi: 10.3390/biomedicines10112922.
7
Mapping of developmental dysplasia of the hip to two novel regions at 8q23-q24 and 12p12.髋关节发育不良与8q23-q24和12p12两个新区域的关联定位
Exp Ther Med. 2020 Apr;19(4):2799-2803. doi: 10.3892/etm.2020.8513. Epub 2020 Feb 11.
8
Paricalcitol accelerates BACE1 lysosomal degradation and inhibits calpain-1 dependent neuronal loss in APP/PS1 transgenic mice.帕立骨化醇加速 BACE1 溶酶体降解并抑制 APP/PS1 转基因小鼠中钙蛋白酶-1 依赖性神经元丢失。
EBioMedicine. 2019 Jul;45:393-407. doi: 10.1016/j.ebiom.2019.07.014. Epub 2019 Jul 11.
9
Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.维生素D的使用对阿尔茨海默病患者精神症状结局的影响。
Am J Geriatr Psychiatry. 2019 Sep;27(9):908-917. doi: 10.1016/j.jagp.2019.03.016. Epub 2019 Mar 27.
10
The etiological effect of a new low-frequency variant on Mild Cognitive Impairment and Alzheimer's Disease: a population-based study.一种新的低频变异对轻度认知障碍和阿尔茨海默病的病因学影响:一项基于人群的研究。
Aging (Albany NY). 2018 Sep 16;10(9):2316-2337. doi: 10.18632/aging.101548.